Clinical Trial Detail

NCT ID NCT01744223
Title Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

lymphoma

Therapies

Rimiducid

BPX-501

Age Groups: adult

No variant requirements are available.